Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience.

Abdul Waris Misbahud Din Atiqa Khalid Raees Abbas LailAsmat ShaheenNida KhanMehboob NawazAbdul BasetImtiaz AhmadMuhammad Ali

Published in: Journal of clinical laboratory analysis (2021)

These blood parameters could be used as a suitable biomarker for the prognosis and severity of COVID-19. Evaluating novel hemograms NLR, PLR, and LMR can aid clinicians to identify potentially severe cases at early stages, initiate effective management in time, and conduct early triage which may reduce the overall mortality of COVID-19 patients.

Keyphrases

sars cov
coronavirus disease
emergency department
cardiovascular events
palliative care
early onset
respiratory syndrome coronavirus
cardiovascular disease